Ed Bell | IR |
Adam Craig | President and CEO |
David Kirske | CFO |
Bruce Seeley | COO |
Jack Singer | Chief Scientific Officer |
Matthew Andrews | Jefferies |
Bert Hazlett | BTIG |
Good day and welcome to the CTI BioPharma Third Quarter 2017 Financial Results Conference Call. Today's conference is being recorded. At this time, I would like to turn the conference over to Ed Bell, Investor Relations. Please go ahead, sir.
Thanks, and welcome to our third quarter financial results conference call.